Jubilant Pharmova Announces Record Profits and 500% Dividend for FY 2024-25: A Deep Dive into Financial Resilience and Strategic Growth
Mumbai, May 16, 2025 – Jubilant Pharmova Limited (BSE: 530019, NSE: JUBLPHARMA), a global integrated pharmaceutical and life sciences company, has unveiled its audited financial results
Read More